Psoriasis trials in Italy

In Italy 22 Also abroad 274

22 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 4Taking people
An open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment
Where
Florence, Reggio Emilia
People
339 worldwide
Run by
Novartis Pharma AG
See details and how to joinNCT04638647 · EU 2023-504417-67-00
Phase 3Taking people
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Where
Bergamo, Bologna, Rome, San Giovanni Rotondo, Trieste
Age
3 years to 64 years
People
196 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00
No phaseTaking people
A Study of Guselkumab in Participants With Psoriatic Arthritis (PsA) in a Real-World Setting
Where
Bari, Brescia, Iesi, Milan, Naples, Palermo, Pavia, Perugia, Pisa, Potenza, Reggio Emilia, Roma, Siena, Torino, Varese, Verona
Age
18 years and over
People
200
Run by
Janssen Research & Development, LLC
See details and how to joinNCT07220824
Phase 3Taking people
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Where
Cagliari, Chieti Scalo, L'aquila, Modena, Naples, Rome, Rozzano
Age
40 years and over
People
3,040 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07116967 · EU 2023-503766-24-00
Phase 3Taking people
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Where
Bologna, Rome
Age
12 years to 17 years
People
366 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT06979453 · EU 2023-506296-97-00
No phaseTaking people
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Where
Rome
Age
Up to 21 years
People
20,000 worldwide
Run by
Duke University
See details and how to joinNCT02418442
Phase 3Taking people
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Where
Ancona, Florence, Milan, Padova, Pisa, Rome, Rozzano
Age
18 years and over
People
1,088 worldwide
Run by
Takeda
See details and how to joinNCT06671483 · EU 2024-513111-27-00
No phaseTaking people
Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis
Where
Genova, L’Aquila, Milan, Naples, Rome
Age
18 years and over
People
700 worldwide
Run by
AbbVie
See details and how to joinNCT07039110
Phase 3Taking people
A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
Where
Catania, Padova, Rome
Age
4 years to 17 years
People
110 worldwide
Run by
Takeda
See details and how to joinNCT07250802 · EU 2025-522567-15-00
Phase 3Taking people
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Where
Ancona, Florence, Milan, Padova, Pisa, Rome, Rozzano
Age
18 years and over
People
1,182 worldwide
Run by
Takeda
See details and how to joinNCT07286058 · EU 2025-522586-30-00
Phase 3Taking people
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
Where
Florence, Milan, Rome
Age
5 years to 17 years
People
40 worldwide
Run by
AbbVie
See details and how to joinNCT06100744 · EU 2023-506026-36-00
No phaseTaking people
Clinical Study on the Medical Devices PROXERA PSOMED 20 and PROXERA PSOMED 40 for the Treatment of Plaque Psoriasis and Non-pustular Palmoplantar Psoriasis
Where
Chieti
Age
18 years to 65 years
People
35
Run by
ICIM International S.r.l.
See details and how to joinNCT07545902
No phaseTaking people
Clinical Study on the Medical Device PROXERA PSOMED 30 for the Treatment of Nail Psoriasis: Evaluation of Safety and Efficacy
Where
Chieti
Age
18 years to 65 years
People
21
Run by
ICIM International S.r.l.
See details and how to joinNCT07546032
Phase 3Taking people
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled and Deucravacitinib Active Comparator-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
Where
Cagliari, Ferrara, Milan, Naples, Novara
Age
18 years and over
People
320 worldwide
Run by
Janssen - Cilag International
See details and how to join2023-505121-14-00 · EU 2023-505121-14-00
No phaseTaking people
An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis
Where
Ancona, Brescia, Campobasso, Catania, Chieti, Milan, Naples, Pisa, Rome, Rozzano, Siena, Udine
Age
18 years to 75 years
People
1,200 worldwide
Run by
AbbVie
See details and how to joinNCT06764693
Phase 3Taking people
Study to Assess Efficacy, Safety and Tolerability of a Nail Patch in Patients With Nail Fragility, Mychosis, Psoriasis
Where
Milan
Age
18 years and over
People
72
Run by
Wooshin Labottach Co., Ltd.
See details and how to joinNCT07029516
No phaseNot yet taking people in Italy
LANDSCAPE: Demographics and Treatment Patterns of Patients With Immune-Mediated Inflammatory Skin Diseases in Italian Clinical Practice
Where
Rozzano
Age
12 years and over
People
20,000
Run by
Fondazione ISIDE
See details and how to joinNCT07336641
No phaseTaking people
Dietary Approach to Mild-to-moderate Psoriasis
Where
Palermo
Age
18 years to 65 years
People
82
Run by
University of Palermo
See details and how to joinNCT05644782
No phaseTaking people
Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis
Where
Roma
Age
18 years and over
People
400
Run by
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT06801821
Phase 4Taking people
Potential Role of Guselkumab in Modulating PAIN Perception and Related Gene Pathways: a Proof-of-concept Study.
Where
Rome
Age
18 years to 80 years
People
26
Run by
Fondazione Policlinico Universitario Campus Bio-Medico
See details and how to joinNCT06974474
No phaseTaking people
Immune Infiltrate Analysis of Psoriasis Skin During Therapy With Anti-interleukin 23 (IL-23)
Where
Rome
Age
18 years and over
People
20
Run by
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT06792487
No phaseTaking people
International Rare And Severe Psoriasis Expert Network
Where
Rome
Age
6 months and over
People
180 worldwide
Run by
University Hospital, Basel, Switzerland
See details and how to joinNCT04359394